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This special issue of the International Journal of Nephrology
is the ﬁrst nephrology journal edition devoted solely to the
discussion of the cardiorenal syndrome and represents a
landmark state-of-the-art discussion on such pathological
entity. The cardiorenal syndrome (CRS) was ﬁrst oﬃcially
deﬁned ata consensusconferenceof the AcuteDialysisQual-
ity Initiative in 2009 [1]. This deﬁnition was made in the
attempt to characterize and classify the various connec-
tions between acute and chronic heart and kidney disease.
Although well known, heart and kidney interactions had not
been clearly deﬁned in the past nor were they completely
elucidated and classiﬁed. The consensus conference deﬁned
5 forms of heart-kidney interaction that would lay the foun-
dation for both a common language in describing patients
suﬀering from these syndromes as well as forming a schema
for further research. The consensus conference recognized
that communication between the heart and kidneys occurs
through a variety of pathways that in the healthy state mod-
ulate cardiac output, vascular tone, maintenance of volume
state, and excretion of waste products. However, a change in
the performance of one of these organs elicits a cascade of
mediatorsthataﬀectstheotherandleadstoaspiralofmutual
organ dysfunction.
T h eﬁ v ef o r m so ft h eC R Si n c l u d e( 1 )t y p eIC R Sw h e r e
acute heart failure is directly associated with acute kidney
injury (AKI); (2) type II CRS in which chronic heart failure
is associated with chronic kidney disease (CKD); (3) type
III CRS where AKI is associated with acute heart failure; (4)
type 4 CRS in which the driving factor of CKD is associated
with chronic heart failure; (5) type 5 CRS where there is
concomitant development of both kidney and heart failure.
The importance of having such a classiﬁcation scheme is due
to the fact that both cardiovascular disease (CVD) and CKD
are highly prevalent and overlapping conditions. For in-
stance, it is estimated that 1 in 3 adults in the United States
(US) (>100 million persons) has a diagnosis of some form
of CVD (hypertension, coronary heart disease, heart failure
(HF), stroke, or congenital heart disease), and nearly 13%
of the US population has been estimated to have some form
of CKD [2, 3]. Much of this disease burden occurs in the
same patient as acute, and chronic abnormalities in cardiac
function are associated with an increased risk for kidney
injury, and patients with both AKI and CKD have a large
burden of CVD [2–6]. For example, in the ADHERE study
database of hospital admission for acute decompensated
heartfailure(ADHF),27.4%,43.5%,and13.1%ofallpatient
admissions were found to have mild, moderate, or severe
kidney dysfunction, respectively [6]. It is thought that the
overlap between CVD and kidney dysfunction represents
common pathophysiological processes that interact in dele-
terious ways to promote a cycle of organ dysfunction. These
critical, dynamic, and bidirectional interactions include
varied pathophysiological pathways that are discussed in this
special edition. These pathways range from hemodynamic
interactions to widespread inﬂammation that aﬀects multi-
ple organ systems. As with any newly described syndrome,
the questions outnumber the answers and papers in this
edition attempt to oﬀer both hypothesis for how organ
crosstalk may occur between the heart and kidney, as well
as describe important diagnostic aids for CRS, and potential
therapies that may improve cardiac and kidney function and
deﬁne questions that will require further elucidation.2 International Journal of Nephrology
Given both the prevalence and the impact of the CRS,
it is clear that there is a mandate for more research in this
evolving area. This journal edition represents a beginning on
the road to answers.
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